{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:38:00Z","timestamp":1788781080676,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.carrev.2025.06.037","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:44:14Z","timestamp":1751431454000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Patent foramen ovale closure vs medical therapy in secondary prevention of stroke and TIA: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"85","author":[{"given":"Amer","family":"Hammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Own","family":"Khraisat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noman","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasr","family":"Al Rayess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdallah","family":"Ashkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Challita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Bikkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Shamoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Vasudev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.carrev.2025.06.037_bb0005","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2025.06.037_bb0015","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2025.06.037_bb0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.carrev.2025.06.037_bb0040","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2025.06.037_bb0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.carrev.2025.06.037_bb0050","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2025.06.037_bb0060","first-page":"e364","article-title":"Guideline for the prevention of stroke in patients with stroke and transient ischemic attack","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.carrev.2025.06.037_bb0080","series-title":"Proceedings of the Semantics Scholar API","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.carrev.2025.06.037_bb0085","series-title":"Review Manager (RevMan) [Computer Program]. Version 5.4","author":"Cochrane Training","year":"2020"},{"issue":"2","key":"10.1016\/j.carrev.2025.06.037_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"10.1016\/j.carrev.2025.06.037_bb0095","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.carrev.2025.06.037_bb0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.carrev.2025.06.037_bb0105","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.037_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer\u2019s guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carrev.2025.06.037_bb0115","author":"Higgins"},{"issue":"7109","key":"10.1016\/j.carrev.2025.06.037_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.carrev.2025.06.037_bb0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00059-020-04921-3","article-title":"Surgical vs. drug therapy in patients with patent foramen ovale and cryptogenic stroke","volume":"46","author":"Liu","year":"2021","journal-title":"Herz"},{"issue":"9","key":"10.1016\/j.carrev.2025.06.037_bb0130","first-page":"16281","article-title":"Recurrent cerebrovascular events in patients with a history of cryptogenic stroke or transient ischemic attack and patent foramen ovale in a long-term follow-up","volume":"132","author":"Weglarz","year":"2022","journal-title":"Polish Arch Intern Med"},{"issue":"3","key":"10.1016\/j.carrev.2025.06.037_bb0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3349\/ymj.2016.57.3.621","article-title":"Comparison of outcomes after device closure and medication alone in patients with patent foramen ovale and cryptogenic stroke in Korean population","volume":"57","author":"Moon","year":"2016","journal-title":"Yonsei Med J"},{"issue":"9","key":"10.1016\/j.carrev.2025.06.037_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003470","article-title":"Propensity score- based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale: the IPSYS registry","volume":"9","author":"Pezzini","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.06.037_bb0145","doi-asserted-by":"crossref","first-page":"1190011","DOI":"10.3389\/fneur.2023.1190011","article-title":"Patent foramen ovale closure in non-elderly and elderly patients with cryptogenic stroke: a hospital-based cohort study","volume":"14","author":"Chen","year":"2023","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.037_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0317167100004674","article-title":"Stroke recurrence and its prevention in patients with patent foramen ovale","volume":"33","author":"Harrer","year":"2006","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.037_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2010.10.032","article-title":"Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure","volume":"156","author":"Faggiano","year":"2012","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2025.06.037_bb0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000321334","article-title":"Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI study","volume":"31","author":"Paciaroni","year":"2011","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.carrev.2025.06.037_bb0165","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2004.05.044","article-title":"Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke","volume":"44","author":"Windecker","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.037_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2004.03.005","article-title":"Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale","volume":"101","author":"Schuchlenz","year":"2005","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2025.06.037_bb0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10072-006-0524-z","article-title":"Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study","volume":"26","author":"Cerrato","year":"2006","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.carrev.2025.06.037_bb0180","first-page":"741","article-title":"Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke","volume":"68","author":"Thanopoulos","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.037_bb0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S0317167100005825","article-title":"Recurrent stroke\/TIA in cryptogenic stroke patients with patent foramen ovale","volume":"34","author":"Casaubon","year":"2007","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.037_bb0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2010.02.025","article-title":"Association between anatomic features of atrial septal abnormalities obtained by omni- plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale","volume":"106","author":"Lee","year":"2010","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2025.06.037_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S1047951112000029","article-title":"A model of multi- disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale","volume":"22","author":"Mazzucco","year":"2012","journal-title":"Cardiol Young"},{"issue":"6","key":"10.1016\/j.carrev.2025.06.037_bb0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score- matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.06.037_bb0205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00415-012-6629-9","article-title":"Management of right- to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry","volume":"260","author":"Horner","year":"2013","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.carrev.2025.06.037_bb0210","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2459\/JCM.0000000000000138","article-title":"Patent foramen ovale treatment strategy: an Italian large prospective study","volume":"15","author":"Alushi","year":"2014","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.carrev.2025.06.037_bb0215","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijcard.2015.05.088","article-title":"Recurrent stroke in patients with patent foramen ovale: an observational prospective study of percutaneous closure of PFO versus non-closure","volume":"195","author":"Mirzada","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2025.06.037_bb0220","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/00015385.2017.1307668","article-title":"Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale","volume":"72","author":"Danese","year":"2017","journal-title":"Acta Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2025.06.037_bb0225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/joic.12430","article-title":"Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke","volume":"31","author":"Kim","year":"2018","journal-title":"J Interv Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2025.06.037_bb0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s42466-021-00114-3","article-title":"Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series","volume":"3","author":"Poli","year":"2021","journal-title":"Neurol Res Pract"},{"issue":"12","key":"10.1016\/j.carrev.2025.06.037_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107407","article-title":"Propensity-score matched analysis of patent foramen ovale closure in real- world study cohort with cryptogenic ischemic stroke","volume":"32","author":"Low","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"15","key":"10.1016\/j.carrev.2025.06.037_bb0240","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030321","article-title":"Effectiveness of transcatheter closure of patent foramen ovale in clinical practice","volume":"12","author":"Alkhouli","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.carrev.2025.06.037_bb0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5853\/jos.2023.03265","article-title":"Device closure or antithrombotic therapy after cryptogenic stroke in elderly patients with a high-risk patent foramen Ovale","volume":"26","author":"Lee","year":"2024","journal-title":"J Stroke"},{"issue":"3","key":"10.1016\/j.carrev.2025.06.037_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24251","article-title":"Patent foramen ovale closure versus drug therapy in patients over 60\u00a0years and a follow-up of 5\u00a0years","volume":"47","author":"Eichelmann","year":"2024","journal-title":"Clin Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2025.06.037_bb0255","first-page":"3456","article-title":"Meta-analysis of PFO closure versus medical therapy for secondary prevention of stroke","volume":"27","author":"Zhang","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.carrev.2025.06.037_bb0260","first-page":"e112","article-title":"Comparative effectiveness of PFO closure and medical therapy in preventing recurrent stroke: a meta-analysis","volume":"52","author":"Pan","year":"2021","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.carrev.2025.06.037_bb0265","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2022.3248","article-title":"Association of atrial septal aneurysm and shunt size with stroke recurrence and benefit from patent foramen ovale closure","volume":"79","author":"Mas","year":"2022","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.carrev.2025.06.037_bb0270","doi-asserted-by":"crossref","first-page":"514","DOI":"10.5551\/jat.56440","article-title":"Atrial septal aneurysm may cause in-hospital recurrence of cryptogenic stroke","volume":"28","author":"Kuriki","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.carrev.2025.06.037_bb0275","article-title":"Outcomes of PFO closure in different patient populations: a systematic review","volume":"198","author":"Gang","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"issue":"23","key":"10.1016\/j.carrev.2025.06.037_bb0285","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.carrev.2025.06.037_bb0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/23969873221076971","article-title":"Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: a systematic review and meta-analysis","volume":"7","author":"Hariharan","year":"2022","journal-title":"Eur Stroke J"},{"issue":"11","key":"10.1016\/j.carrev.2025.06.037_bb0295","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/STROKEAHA.117.018501","article-title":"Safety outcomes after percutaneous transcatheter closure of patent foramen ovale","volume":"48","author":"Merkler","year":"2017","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.carrev.2025.06.037_bb0300","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/cns.12980","article-title":"Patent foramen ovale closure for patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 5 randomized controlled trials and 14 observational studies","volume":"24","author":"Chen","year":"2018","journal-title":"CNS Neurosci Ther"},{"issue":"17","key":"10.1016\/j.carrev.2025.06.037_bb0305","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4244\/EIJ-D-18-00767","article-title":"New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials","volume":"14","author":"Elgendy","year":"2019","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.carrev.2025.06.037_bb0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.amjcard.2014.12.051","article-title":"Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale","volume":"115","author":"Patti","year":"2015","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:40:51Z","timestamp":1777074051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925003513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"alternative-id":["S1553838925003513"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.06.037","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patent foramen ovale closure vs medical therapy in secondary prevention of stroke and TIA: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}